학술논문

Cost-effectiveness analysis of caplacizumab in the new standard of care of immune thrombotic thrombocytopenic purpura in Italy
Document Type
Article
Source
In: Global and Regional Health Technology Assessment. (Global and Regional Health Technology Assessment, July 2021, 8:43-52)
Subject
Language
English
ISSN
22835733
22842403